Clean Yield Group Novo Nordisk A S Transaction History

Clean Yield Group

$293 Million
Q4 2024

A detailed history of Clean Yield Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Clean Yield Group holds 33,876 shares of NVO stock, worth $2.98 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

33,876

Previous 34,386 1.48%

Holding current value

$2.98 Million

Previous $4.09 Million 28.82%

% of portfolio

0.99%

Previous 1.38%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$85.0 - $120.04 $43,350 - $61,220	-510 Reduced 1.48%	33,876 $2.91 Million
Q3 2024 Oct 07, 2024	SELL	$119.07 - $145.42 $93,350 - $114,009	-784 Reduced 2.23%	34,386 $4.09 Million
Q2 2024 Jul 10, 2024	SELL	$122.71 - $146.91 $109,457 - $131,043	-892 Reduced 2.47%	35,170 $5.02 Million
Q1 2024 May 29, 2024	SELL	$102.11 - $135.92 $393,634 - $523,971	-3,855 Reduced 9.66%	36,062 $4.63 Million
Q4 2023 Jan 24, 2024	SELL	$87.78 - $105.45 $74,174 - $89,105	-845 Reduced 2.07%	39,917 $4.13 Million
Q3 2023 Oct 12, 2023	BUY	$90.94 - $199.54 $1.96 Million - $4.31 Million	21,581 Added 112.51%	40,762 $3.71 Million
Q2 2023 Jul 26, 2023	SELL	$155.98 - $172.65 $125,563 - $138,983	-805 Reduced 4.03%	19,181 $3.1 Million
Q1 2023 Apr 26, 2023	SELL	$132.34 - $159.14 $183,290 - $220,408	-1,385 Reduced 6.48%	19,986 $3.18 Million
Q4 2022 Jan 31, 2023	SELL	$102.55 - $135.33 $40,507 - $53,455	-395 Reduced 1.81%	21,371 $2.89 Million
Q3 2022 Oct 31, 2022	SELL	$95.28 - $116.93 $9,528 - $11,693	-100 Reduced 0.46%	21,766 $2.17 Million
Q2 2022 Jul 18, 2022	SELL	$103.24 - $121.81 $81,559 - $96,229	-790 Reduced 3.49%	21,866 $2.44 Million
Q1 2022 Apr 25, 2022	SELL	$93.1 - $112.54 $466,151 - $563,487	-5,007 Reduced 18.1%	22,656 $2.52 Million
Q4 2021 Jan 24, 2022	SELL	$95.88 - $117.08 $58,870 - $71,887	-614 Reduced 2.17%	27,663 $3.1 Million
Q3 2021 Oct 27, 2021	SELL	$84.42 - $106.62 $35,456 - $44,780	-420 Reduced 1.46%	28,277 $2.72 Million
Q2 2021 Jul 26, 2021	SELL	$67.66 - $84.76 $218,880 - $274,198	-3,235 Reduced 10.13%	28,697 $2.4 Million
Q1 2021 Apr 26, 2021	SELL	$67.06 - $75.82 $136,131 - $153,914	-2,030 Reduced 5.98%	31,932 $2.15 Million
Q4 2020 Jan 26, 2021	SELL	$63.89 - $73.8 $78,584 - $90,774	-1,230 Reduced 3.5%	33,962 $2.37 Million
Q3 2020 Oct 16, 2020	SELL	$63.69 - $70.22 $56,238 - $62,004	-883 Reduced 2.45%	35,192 $2.44 Million
Q2 2020 Jul 22, 2020	SELL	$58.54 - $67.94 $810,076 - $940,153	-13,838 Reduced 27.72%	36,075 $2.36 Million
Q1 2020 Apr 20, 2020	SELL	$49.46 - $64.78 $433,813 - $568,185	-8,771 Reduced 14.95%	49,913 $3.01 Million
Q4 2019 Jan 17, 2020	SELL	$49.86 - $58.26 $62,823 - $73,407	-1,260 Reduced 2.1%	58,684 $3.4 Million
Q3 2019 Oct 23, 2019	SELL	$47.54 - $53.43 $62,039 - $69,726	-1,305 Reduced 2.13%	59,944 $3.1 Million
Q2 2019 Jul 22, 2019	SELL	$46.79 - $52.47 $131,339 - $147,283	-2,807 Reduced 4.38%	61,249 $3.13 Million
Q1 2019 Apr 24, 2019	SELL	$46.36 - $52.63 $14,835 - $16,841	-320 Reduced 0.5%	64,056 $3.35 Million
Q4 2018 Jan 23, 2019	SELL	$41.54 - $47.25 $77,305 - $87,932	-1,861 Reduced 2.81%	64,376 $2.97 Million
Q3 2018 Oct 22, 2018	SELL	$46.76 - $51.24 $7,995 - $8,762	-171 Reduced 0.26%	66,237 $3.12 Million
Q2 2018 Jul 24, 2018	SELL	$44.29 - $50.42 $103,195 - $117,478	-2,330 Reduced 3.39%	66,408 $3.06 Million
Q1 2018 Apr 23, 2018	SELL	$48.49 - $58.14 $433,258 - $519,480	-8,935 Reduced 11.5%	68,738 $3.39 Million
Q4 2017 Jan 16, 2018	SELL	$47.53 - $53.73 $43,727 - $49,431	-920 Reduced 1.17%	77,673 $4.17 Million
Q3 2017 Oct 11, 2017	BUY	$41.15 - $49.22 $3.23 Million - $3.87 Million	78,593	78,593 $3.78 Million

Others Institutions Holding NVO

# of Institutions

1,904

Shares Held

317M

Call Options Held

5.49M

Put Options Held

7.77M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.

Account

Clean Yield Group Novo Nordisk A S Transaction History